Likewise, BRCA1 methylation in ovarian cancer (~16%) mirrors BRCA1 genetic loss and correlates (in certain assay types) with treatment response, supporting methylation as both a functional alteration and a biomarker across cancers [92]. Here, BRCA1 is linked to ovarian cancer.